Company news
OPKO Health, Inc. news in 2020
OPKO Health, Inc.'s news releases, calls and decks from 2020, newest first.
Buffalo Bills and OPKO Health's BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Program
December 30, 2020
OPKO Health Appoints Dr. Roger Medel to its Board of Directors
December 20, 2020
OPKO Health to Participate in Three Upcoming Investment Conferences
November 10, 2020
OPKO Health Reports 2020 Third Quarter Business Highlights and Financial Results
October 28, 2020
OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test
October 19, 2020
OPKO Health to Report Third Quarter 2020 Financial Results on October 29, 2020
October 12, 2020
OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools
October 8, 2020
OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients
September 14, 2020
OPKO Health to Participate in Two September Investment Conferences
September 1, 2020
OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing Program
September 1, 2020
OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay
August 31, 2020
OPKO Health's GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services
August 11, 2020
OPKO Health's GeneDx Adds GenomeXpress to Its Industry-Leading Clinical Genomics Portfolio
August 5, 2020
OPKO Health to Participate in BTIG Virtual Biotechnology Conference
August 4, 2020
OPKO Health Reports 2020 Second Quarter Business Highlights and Financial Results
July 29, 2020
OPKO Health to Report Second Quarter 2020 Financial Results on July 30, 2020
July 26, 2020
OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC)
July 19, 2020
OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for National Basketball Association Players and Employees
July 12, 2020
Major League Soccer Chooses OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for Players and Employees
July 8, 2020
OPKO Health Announces Positive Top-Line Results of Phase 3 Efficacy and Safety Study of Somatrogon for the Treatment of Japanese Children with Growth Hormone Deficiency
June 8, 2020
FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients
May 31, 2020
OPKO Health to Present at the Jefferies Virtual Healthcare Conference
May 26, 2020
OPKO Health Reports 2020 First Quarter Business Highlights and Financial Results
May 5, 2020
OPKO Health to Report First Quarter 2020 Financial Results on May 6, 2020
April 29, 2020
Somatrogon Phase 3 Pediatric Trial Results will be presented on June 8 at ENDO Online 2020
April 21, 2020
OPKO Health Reports Interim Results for Two Ongoing RAYALDEE Studies
March 24, 2020
OPKO Health Reports 2019 Fourth Quarter Business Highlights and Financial Results
February 25, 2020
OPKO Health to Report Fourth Quarter 2019 Financial Results on February 26, 2020
February 19, 2020
Calls in 2020
Decks in 2020
- Investor Presentation (September 2020)
Investor deck · 24 slides · Sep 15, 2020